149 related articles for article (PubMed ID: 34624333)
1. Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet.
Lopresti MW; Cui W; Abernathy BE; Fredrickson G; Barrow F; Desai AS; Revelo XS; Mashek DG
J Lipid Res; 2021; 62():100133. PubMed ID: 34624333
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lysosomal acid lipase drives the autophagy-lysosomal response and alleviates cholesterol metabolic disorder in ApoE deficient mice.
Li F; Zhao X; Li H; Liu Y; Zhang Y; Huang X; Cao J; Du F; Wu D; Yu H
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159027. PubMed ID: 34416392
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
Bradić I; Liesinger L; Kuentzel KB; Vujić N; Trauner M; Birner-Gruenberger R; Kratky D
J Lipid Res; 2023 Sep; 64(9):100427. PubMed ID: 37595802
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific deletion of lysosomal acid lipase leads to cholesteryl ester but not triglyceride or retinyl ester accumulation.
Pajed L; Wagner C; Taschler U; Schreiber R; Kolleritsch S; Fawzy N; Pototschnig I; Schoiswohl G; Pusch LM; Wieser BI; Vesely P; Hoefler G; Eichmann TO; Zimmermann R; Lass A
J Biol Chem; 2019 Jun; 294(23):9118-9133. PubMed ID: 31023823
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation.
Leopold C; Duta-Mare M; Sachdev V; Goeritzer M; Maresch LK; Kolb D; Reicher H; Wagner B; Stojakovic T; Ruelicke T; Haemmerle G; Hoefler G; Sattler W; Kratky D
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):500-511. PubMed ID: 30639734
[TBL] [Abstract][Full Text] [Related]
6. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
[TBL] [Abstract][Full Text] [Related]
7. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.
Carotti S; Lettieri-Barbato D; Piemonte F; Ruggiero S; Rosina M; Zalfa F; Zingariello M; Arciprete F; Valentini F; Francesconi M; D'Amico J; De Vincentis A; Baiocchini A; Perrone G; Antonelli-Incalzi R; Morini S; Picardi A; Aquilano K; Vespasiani-Gentilucci U
Cell Death Dis; 2021 Nov; 12(12):1092. PubMed ID: 34795230
[TBL] [Abstract][Full Text] [Related]
8. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase.
Carotti S; Aquilano K; Valentini F; Ruggiero S; Alletto F; Morini S; Picardi A; Antonelli-Incalzi R; Lettieri-Barbato D; Vespasiani-Gentilucci U
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G469-G480. PubMed ID: 32812776
[TBL] [Abstract][Full Text] [Related]
9. Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.
Aqul A; Lopez AM; Posey KS; Taylor AM; Repa JJ; Burns DK; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G836-47. PubMed ID: 25147230
[TBL] [Abstract][Full Text] [Related]
10. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
Carter A; Brackley SM; Gao J; Mann JP
J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.
Chuang JC; Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Jan; 443(3):1073-7. PubMed ID: 24370824
[TBL] [Abstract][Full Text] [Related]
12. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
Pasta A; Borro P; Cremonini AL; Formisano E; Tozzi G; Cecchi S; Fresa R; Labanca S; Djahandideh A; Sukkar SG; Picciotto A; Pisciotta L
Pharmacol Res Perspect; 2021 Oct; 9(5):e00820. PubMed ID: 34476902
[TBL] [Abstract][Full Text] [Related]
13. Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures.
Gomaraschi M; Fracanzani AL; Dongiovanni P; Pavanello C; Giorgio E; Da Dalt L; Norata GD; Calabresi L; Consonni D; Lombardi R; Branchi A; Fargion S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158523. PubMed ID: 31505261
[TBL] [Abstract][Full Text] [Related]
14. PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.
Lopez AM; Chuang JC; Posey KS; Ohshiro T; Tomoda H; Rudel LL; Turley SD
J Pharmacol Exp Ther; 2015 Nov; 355(2):159-67. PubMed ID: 26283692
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal(-/-) Mice.
Du H; Zhao T; Ding X; Yan C
Am J Pathol; 2015 Sep; 185(9):2379-89. PubMed ID: 26212911
[TBL] [Abstract][Full Text] [Related]
16. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
[TBL] [Abstract][Full Text] [Related]
17. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
Maciejko JJ
Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
[TBL] [Abstract][Full Text] [Related]
18. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
[TBL] [Abstract][Full Text] [Related]
19. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.
Yang Y; Li X; Liu Z; Ruan X; Wang H; Zhang Q; Cao L; Song L; Chen Y; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432597
[TBL] [Abstract][Full Text] [Related]
20. Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse.
Lopez AM; Chuang JC; Turley SD
Steroids; 2018 Feb; 130():7-14. PubMed ID: 29246491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
